Thermo Fisher Scientific has inaugurated a new Bioprocess Design Center in Hyderabad, India, while expanding its existing facilities in Korea and Singapore. The move strengthens its Asia-Pacific network, offering advanced bioprocessing technologies, training, and collaborative opportunities to support the region’s fast-growing biopharmaceutical ecosystem.
Inside the announcement
According to Business Wire, The Hans India, and The Hindu Business Line, Thermo Fisher’s Hyderabad center, located in Genome Valley, was launched in partnership with the Government of Telangana and India’s Department of Biotechnology. The facility will serve as a hub for scaling bioprocess technologies, offering hands-on training, and supporting innovations in cell and gene therapy, mRNA, oncology, and proteomics. With expansions in Incheon and Singapore, the company aims to accelerate biomanufacturing efficiency and sustainability across Asia.
Notable updates
• New Bioprocess Design Center inaugurated in Hyderabad’s Genome Valley
• Expanded centers in Incheon, Korea, and Singapore to strengthen regional presence
• Hyderabad facility showcases over 50 integrated workflows across 20+ therapeutic applications
• Partnerships with Telangana government and Department of Biotechnology highlight public-private collaboration
• Combined investment of Rs 85–90 crore in Hyderabad facilities, including a Customer Experience Center
• Centers designed to enhance speed, efficiency, and sustainability in biomanufacturing
Major takeaway
Thermo Fisher’s expansion underscores Asia’s emergence as a global biopharma hub. By investing in infrastructure and collaborative platforms, the company is positioning itself as a key enabler of innovation, supporting the region’s demand for biologics, vaccines, and advanced therapies.
Sources: Business Wire, The Hans India, The Hindu Business Line